Phase III study of Efficacy and Safety of SJP-0118 compared to Vehicle and Levofloxacin in the treatment of bacterial conjunctivitis.
Phase of Trial: Phase III
Latest Information Update: 29 Jul 2016
At a glance
- Drugs SJP 0118 (Primary) ; Levofloxacin
- Indications Infectious conjunctivitis
- Focus Therapeutic Use
- Sponsors Senju Pharmaceutical
- 28 Jul 2016 Status changed from recruiting to completed.
- 27 Aug 2015 New trial record